Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (21-30 of 339) with videos related to

Pageof 34
Sort By:
Nature Reviews. Clinical Oncology|June 20, 2012
Haematological cancer: The rule of three in AML induction--is cladribine the answer?Frederick R Appelbaum
Best Practice & Research. Clinical Haematology|December 7, 2010
Dose intensity of preparative regimens for acute myeloid leukemia - one-size-fits-all or tailor-made?Frederick R Appelbaum
Best Practice & Research. Clinical Haematology|March 6, 2007
Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remissionFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|March 25, 2021
Hypomethylating agents as maintenance therapy following allogeneic hematopoietic cell transplantation for myeloid malignanciesFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|December 6, 2021
Effectiveness of allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemiaFrederick R Appelbaum
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2011
Preparative regimens and ageismFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|November 30, 2019
Maintenance therapy after allogeneic hematopoietic cell transplantation for acute myeloid leukemiaFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|March 18, 2008
Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML)Frederick R Appelbaum
Science (New York, N.Y.)|December 1, 2012
Retrospective. E. Donnall Thomas (1920-2012)Frederick R Appelbaum
Annual Review of Medicine|November 5, 2002
The current status of hematopoietic cell transplantationFrederick R Appelbaum
Pageof 34

Showing results (21-30 of 339) with videos related to

Sort By:
Pageof 34
Nature Reviews. Clinical Oncology|June 20, 2012
Haematological cancer: The rule of three in AML induction--is cladribine the answer?Frederick R Appelbaum
Best Practice & Research. Clinical Haematology|December 7, 2010
Dose intensity of preparative regimens for acute myeloid leukemia - one-size-fits-all or tailor-made?Frederick R Appelbaum
Best Practice & Research. Clinical Haematology|March 6, 2007
Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remissionFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|March 25, 2021
Hypomethylating agents as maintenance therapy following allogeneic hematopoietic cell transplantation for myeloid malignanciesFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|December 6, 2021
Effectiveness of allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemiaFrederick R Appelbaum
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 16, 2011
Preparative regimens and ageismFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|November 30, 2019
Maintenance therapy after allogeneic hematopoietic cell transplantation for acute myeloid leukemiaFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|March 18, 2008
Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML)Frederick R Appelbaum
Science (New York, N.Y.)|December 1, 2012
Retrospective. E. Donnall Thomas (1920-2012)Frederick R Appelbaum
Annual Review of Medicine|November 5, 2002
The current status of hematopoietic cell transplantationFrederick R Appelbaum
Pageof 34